Cancer Biologics Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_0081343
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:7.99
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 7.99 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
Cancer Biologic is a medicinal preparation created by a biological process, it is used to treatment and remission cancer symptoms.In 2018, the global Cancer Biologics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% during 2019-2026.
This report focuses on the global Cancer Biologics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Biologics development in United States, Europe and China.
The key players covered in this study
Roche
Novartis
Eli Lilly
Sanofi
Celgene
Pfizer
Bayer
Johnson & Johnson
Bristol-Myers Squibb
Merck
Amgen
Market segment by Type, the product can be split into
Monoclonal Antibodies
Vaccines
Cell and Gene Therapy
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cancer Biologics status, future forecast, growth opportunity, key market and key players.
To present the Cancer Biologics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cancer Biologics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Biologics Market Size Growth Rate by Type (2014-2025)
1.4.2 Monoclonal Antibodies
1.4.3 Vaccines
1.4.4 Cell and Gene Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Cancer Biologics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cancer Biologics Market Size
2.2 Cancer Biologics Growth Trends by Regions
2.2.1 Cancer Biologics Market Size by Regions (2014-2025)
2.2.2 Cancer Biologics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
3 Market Share by Key Players
3.1 Cancer Biologics Market Size by by Players
3.1.1 Global Cancer Biologics Revenue by by Players (2014-2019)
3.1.2 Global Cancer Biologics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Cancer Biologics Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Biologics Key Players Head office and Area Served
3.3 Key Players Cancer Biologics Product/Solution/Service
3.4 Date of Enter into Cancer Biologics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cancer Biologics Market Size by Type (2014-2019)
4.2 Global Cancer Biologics Market Size by Application (2014-2019)
5 United States
5.1 United States Cancer Biologics Market Size (2014-2019)
5.2 Cancer Biologics Key Players in United States
5.3 United States Cancer Biologics Market Size by Type
5.4 United States Cancer Biologics Market Size by Application
6 Europe
6.1 Europe Cancer Biologics Market Size (2014-2019)
6.2 Cancer Biologics Key Players in Europe
6.3 Europe Cancer Biologics Market Size by Type
6.4 Europe Cancer Biologics Market Size by Application
7 China
7.1 China Cancer Biologics Market Size (2014-2019)
7.2 Cancer Biologics Key Players in China
7.3 China Cancer Biologics Market Size by Type
7.4 China Cancer Biologics Market Size by Application
8 Japan
8.1 Japan Cancer Biologics Market Size (2014-2019)
8.2 Cancer Biologics Key Players in Japan
8.3 Japan Cancer Biologics Market Size by Type
8.4 Japan Cancer Biologics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Cancer Biologics Market Size (2014-2019)
9.2 Cancer Biologics Key Players in Southeast Asia
9.3 Southeast Asia Cancer Biologics Market Size by Type
9.4 Southeast Asia Cancer Biologics Market Size by Application
10 India
10.1 India Cancer Biologics Market Size (2014-2019)
10.2 Cancer Biologics Key Players in India
10.3 India Cancer Biologics Market Size by Type
10.4 India Cancer Biologics Market Size by Application
11 Central & South America
11.1 Central & South America Cancer Biologics Market Size (2014-2019)
11.2 Cancer Biologics Key Players in Central & South America
11.3 Central & South America Cancer Biologics Market Size by Type
11.4 Central & South America Cancer Biologics Market Size by Application
12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Biologics Introduction
12.1.4 Roche Revenue in Cancer Biologics Business (2014-2019)
12.1.5 Roche Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Biologics Introduction
12.2.4 Novartis Revenue in Cancer Biologics Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Biologics Introduction
12.3.4 Eli Lilly Revenue in Cancer Biologics Business (2014-2019)
12.3.5 Eli Lilly Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Biologics Introduction
12.4.4 Sanofi Revenue in Cancer Biologics Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 Celgene
12.5.1 Celgene Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Biologics Introduction
12.5.4 Celgene Revenue in Cancer Biologics Business (2014-2019)
12.5.5 Celgene Recent Development
12.6 Pfizer
12.6.1 Pfizer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Biologics Introduction
12.6.4 Pfizer Revenue in Cancer Biologics Business (2014-2019)
12.6.5 Pfizer Recent Development
12.7 Bayer
12.7.1 Bayer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Biologics Introduction
12.7.4 Bayer Revenue in Cancer Biologics Business (2014-2019)
12.7.5 Bayer Recent Development
12.8 Johnson & Johnson
12.8.1 Johnson & Johnson Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Biologics Introduction
12.8.4 Johnson & Johnson Revenue in Cancer Biologics Business (2014-2019)
12.8.5 Johnson & Johnson Recent Development
12.9 Bristol-Myers Squibb
12.9.1 Bristol-Myers Squibb Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Biologics Introduction
12.9.4 Bristol-Myers Squibb Revenue in Cancer Biologics Business (2014-2019)
12.9.5 Bristol-Myers Squibb Recent Development
12.10 Merck
12.10.1 Merck Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cancer Biologics Introduction
12.10.4 Merck Revenue in Cancer Biologics Business (2014-2019)
12.10.5 Merck Recent Development
12.11 Amgen
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Cancer Biologics Key Market Segments
Table Key Players Cancer Biologics Covered
Table Global Cancer Biologics Market Size Growth Rate by Type 2019-2025 (Million US$)
Figure Global Cancer Biologics Market Share by TypeType in 2018 & 2025
Figure Monoclonal Antibodies Figures
Table Key Players of Monoclonal Antibodies
Figure Vaccines Figures
Table Key Players of Vaccines
Figure Cell and Gene Therapy Figures
Table Key Players of Cell and Gene Therapy
Figure Others Figures
Table Key Players of Others
Table Global Cancer Biologics Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Cancer Biologics Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Cancer Biologics Report Years Considered
Table Global Cancer Biologics Market Size 2014-2025 (Million US$)
Figure Global Cancer Biologics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cancer Biologics Market Size by Regions 2019-2025 (Million US$)
Table Global Cancer Biologics Market Size by Regions 2019-2025 (Million US$)
Table Global Cancer Biologics Market Share by Regions 2014-2019
Figure Global Cancer Biologics Market Share by Regions 2014-2019
Figure Global Cancer Biologics Market Share by Regions 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Cancer Biologics Revenue by by Players (2014-2019) (Million US$)
Table Global Cancer Biologics Market Share by by Players (2014-2019)
Figure Global Cancer Biologics Market Share by by Players in 2018
Table Global Cancer Biologics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cancer Biologics Product/Solution/Service
Table Date of Enter into Cancer Biologics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cancer Biologics Market Size by Type (2014-2019) (Million US$)
Table Global Cancer Biologics Market Size Share by Type (2014-2019)
Figure Global Cancer Biologics Market Size Market Share by Type (2014-2019)
Table Global Cancer Biologics Market Size by Application (2014-2019) (Million US$)
Table Global Cancer Biologics Market Size Share by Application (2014-2019)
Figure Global Cancer Biologics Market Size Market Share by Application (2014-2019)
Figure Global Cancer Biologics Revenue Market Share by Application in 2018
Figure United States Cancer Biologics Market Size 2014-2019 (Million US$)
Table United States Key Players Cancer Biologics Revenue (2018-2019) (Million US$)
Table United States Key Players Cancer Biologics Market Share (2018-2019)
Table United States Cancer Biologics Market Size by Type (2014-2019) (Million US$)
Table United States Cancer Biologics Market Share by Type (2014-2019)
Table United States Cancer Biologics Market Size by Application (2014-2019) (Million US$)
Table United States Cancer Biologics Market Share by Application (2014-2019)
Figure Europe Cancer Biologics Market Size 2014-2019 (Million US$)
Table Europe Key Players Cancer Biologics Revenue (2018-2019) (Million US$)
Table Europe Key Players Cancer Biologics Market Share (2018-2019)
Table Europe Cancer Biologics Market Size by Type (2014-2019) (Million US$)
Table Europe Cancer Biologics Market Share by Type (2014-2019)
Table Europe Cancer Biologics Market Size by Application (2014-2019) (Million US$)
Table Europe Cancer Biologics Market Share by Application (2014-2019)
Figure China Cancer Biologics Market Size 2014-2019 (Million US$)
Table China Key Players Cancer Biologics Revenue (2018-2019) (Million US$)
Table China Key Players Cancer Biologics Market Share (2018-2019)
Table China Cancer Biologics Market Size by Type (2014-2019) (Million US$)
Table China Cancer Biologics Market Share by Type (2014-2019)
Table China Cancer Biologics Market Size by Application (2014-2019) (Million US$)
Table China Cancer Biologics Market Share by Application (2014-2019)
Figure Japan Cancer Biologics Market Size 2014-2019 (Million US$)
Table Japan Key Players Cancer Biologics Revenue (2018-2019) (Million US$)
Table Japan Key Players Cancer Biologics Market Share (2018-2019)
Table Japan Cancer Biologics Market Size by Type (2014-2019) (Million US$)
Table Japan Cancer Biologics Market Share by Type (2014-2019)
Table Japan Cancer Biologics Market Size by Application (2014-2019) (Million US$)
Table Japan Cancer Biologics Market Share by Application (2014-2019)
Figure Southeast Asia Cancer Biologics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cancer Biologics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cancer Biologics Market Share (2018-2019)
Table Southeast Asia Cancer Biologics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Cancer Biologics Market Share by Type (2014-2019)
Table Southeast Asia Cancer Biologics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Cancer Biologics Market Share by Application (2014-2019)
Figure India Cancer Biologics Market Size 2014-2019 (Million US$)
Table India Key Players Cancer Biologics Revenue (2018-2019) (Million US$)
Table India Key Players Cancer Biologics Market Share (2018-2019)
Table India Cancer Biologics Market Size by Type (2014-2019) (Million US$)
Table India Cancer Biologics Market Share by Type (2014-2019)
Table India Cancer Biologics Market Size by Application (2014-2019) (Million US$)
Table India Cancer Biologics Market Share by Application (2014-2019)
Figure Central & South America Cancer Biologics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cancer Biologics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cancer Biologics Market Share (2018-2019)
Table Central & South America Cancer Biologics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Cancer Biologics Market Share by Type (2014-2019)
Table Central & South America Cancer Biologics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Cancer Biologics Market Share by Application (2014-2019)
Table Roche Company Details
Table Roche Revenue in Cancer Biologics Business (2014-2019) (Million US$)
Figure Roche Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Roche Recent Development
Table Novartis Company Details
Table Novartis Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Novartis Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Eli Lilly Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Sanofi Recent Development
Table Celgene Company Details
Table Celgene Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Celgene Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Pfizer Recent Development
Table Bayer Company Details
Table Bayer Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Bayer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Merck Company Details
Table Merck Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Merck Recent Development
Table Amgen Company Details
Table Global Cancer Biologics Market Size by Regions (Million US$) 2019-2025
Figure Global Cancer Biologics Market Size Share by Regions (2019-2025)
Figure Global Cancer Biologics Market Size Share by Regions in 2025
Figure United States Cancer Biologics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cancer Biologics Market Size Forecast (2019-2025)(Million USD)
Figure China Cancer Biologics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cancer Biologics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cancer Biologics Market Size Forecast (2019-2025)(Million USD)
Figure India Cancer Biologics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cancer Biologics Market Size Forecast (2019-2025)(Million USD)
Table Global Cancer Biologics Market Size by Product (2019-2025) (Million US$)
Figure Global Cancer Biologics Market Size by Product (2019-2025)
Figure Global Cancer Biologics Market Size by Product in 2025
Table Global Cancer Biologics Market Size by Application (2019-2025) (Million US$)
Figure Global Cancer Biologics Market Size by Application (2019-2025)
Figure Global Cancer Biologics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Biologics Market Size Growth Rate by Type (2014-2025)
1.4.2 Monoclonal Antibodies
1.4.3 Vaccines
1.4.4 Cell and Gene Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Cancer Biologics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cancer Biologics Market Size
2.2 Cancer Biologics Growth Trends by Regions
2.2.1 Cancer Biologics Market Size by Regions (2014-2025)
2.2.2 Cancer Biologics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
3 Market Share by Key Players
3.1 Cancer Biologics Market Size by by Players
3.1.1 Global Cancer Biologics Revenue by by Players (2014-2019)
3.1.2 Global Cancer Biologics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Cancer Biologics Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Biologics Key Players Head office and Area Served
3.3 Key Players Cancer Biologics Product/Solution/Service
3.4 Date of Enter into Cancer Biologics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cancer Biologics Market Size by Type (2014-2019)
4.2 Global Cancer Biologics Market Size by Application (2014-2019)
5 United States
5.1 United States Cancer Biologics Market Size (2014-2019)
5.2 Cancer Biologics Key Players in United States
5.3 United States Cancer Biologics Market Size by Type
5.4 United States Cancer Biologics Market Size by Application
6 Europe
6.1 Europe Cancer Biologics Market Size (2014-2019)
6.2 Cancer Biologics Key Players in Europe
6.3 Europe Cancer Biologics Market Size by Type
6.4 Europe Cancer Biologics Market Size by Application
7 China
7.1 China Cancer Biologics Market Size (2014-2019)
7.2 Cancer Biologics Key Players in China
7.3 China Cancer Biologics Market Size by Type
7.4 China Cancer Biologics Market Size by Application
8 Japan
8.1 Japan Cancer Biologics Market Size (2014-2019)
8.2 Cancer Biologics Key Players in Japan
8.3 Japan Cancer Biologics Market Size by Type
8.4 Japan Cancer Biologics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Cancer Biologics Market Size (2014-2019)
9.2 Cancer Biologics Key Players in Southeast Asia
9.3 Southeast Asia Cancer Biologics Market Size by Type
9.4 Southeast Asia Cancer Biologics Market Size by Application
10 India
10.1 India Cancer Biologics Market Size (2014-2019)
10.2 Cancer Biologics Key Players in India
10.3 India Cancer Biologics Market Size by Type
10.4 India Cancer Biologics Market Size by Application
11 Central & South America
11.1 Central & South America Cancer Biologics Market Size (2014-2019)
11.2 Cancer Biologics Key Players in Central & South America
11.3 Central & South America Cancer Biologics Market Size by Type
11.4 Central & South America Cancer Biologics Market Size by Application
12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Biologics Introduction
12.1.4 Roche Revenue in Cancer Biologics Business (2014-2019)
12.1.5 Roche Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Biologics Introduction
12.2.4 Novartis Revenue in Cancer Biologics Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Biologics Introduction
12.3.4 Eli Lilly Revenue in Cancer Biologics Business (2014-2019)
12.3.5 Eli Lilly Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Biologics Introduction
12.4.4 Sanofi Revenue in Cancer Biologics Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 Celgene
12.5.1 Celgene Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Biologics Introduction
12.5.4 Celgene Revenue in Cancer Biologics Business (2014-2019)
12.5.5 Celgene Recent Development
12.6 Pfizer
12.6.1 Pfizer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Biologics Introduction
12.6.4 Pfizer Revenue in Cancer Biologics Business (2014-2019)
12.6.5 Pfizer Recent Development
12.7 Bayer
12.7.1 Bayer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Biologics Introduction
12.7.4 Bayer Revenue in Cancer Biologics Business (2014-2019)
12.7.5 Bayer Recent Development
12.8 Johnson & Johnson
12.8.1 Johnson & Johnson Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Biologics Introduction
12.8.4 Johnson & Johnson Revenue in Cancer Biologics Business (2014-2019)
12.8.5 Johnson & Johnson Recent Development
12.9 Bristol-Myers Squibb
12.9.1 Bristol-Myers Squibb Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Biologics Introduction
12.9.4 Bristol-Myers Squibb Revenue in Cancer Biologics Business (2014-2019)
12.9.5 Bristol-Myers Squibb Recent Development
12.10 Merck
12.10.1 Merck Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cancer Biologics Introduction
12.10.4 Merck Revenue in Cancer Biologics Business (2014-2019)
12.10.5 Merck Recent Development
12.11 Amgen
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Cancer Biologics Key Market Segments
Table Key Players Cancer Biologics Covered
Table Global Cancer Biologics Market Size Growth Rate by Type 2019-2025 (Million US$)
Figure Global Cancer Biologics Market Share by TypeType in 2018 & 2025
Figure Monoclonal Antibodies Figures
Table Key Players of Monoclonal Antibodies
Figure Vaccines Figures
Table Key Players of Vaccines
Figure Cell and Gene Therapy Figures
Table Key Players of Cell and Gene Therapy
Figure Others Figures
Table Key Players of Others
Table Global Cancer Biologics Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Cancer Biologics Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Cancer Biologics Report Years Considered
Table Global Cancer Biologics Market Size 2014-2025 (Million US$)
Figure Global Cancer Biologics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cancer Biologics Market Size by Regions 2019-2025 (Million US$)
Table Global Cancer Biologics Market Size by Regions 2019-2025 (Million US$)
Table Global Cancer Biologics Market Share by Regions 2014-2019
Figure Global Cancer Biologics Market Share by Regions 2014-2019
Figure Global Cancer Biologics Market Share by Regions 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Cancer Biologics Revenue by by Players (2014-2019) (Million US$)
Table Global Cancer Biologics Market Share by by Players (2014-2019)
Figure Global Cancer Biologics Market Share by by Players in 2018
Table Global Cancer Biologics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cancer Biologics Product/Solution/Service
Table Date of Enter into Cancer Biologics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cancer Biologics Market Size by Type (2014-2019) (Million US$)
Table Global Cancer Biologics Market Size Share by Type (2014-2019)
Figure Global Cancer Biologics Market Size Market Share by Type (2014-2019)
Table Global Cancer Biologics Market Size by Application (2014-2019) (Million US$)
Table Global Cancer Biologics Market Size Share by Application (2014-2019)
Figure Global Cancer Biologics Market Size Market Share by Application (2014-2019)
Figure Global Cancer Biologics Revenue Market Share by Application in 2018
Figure United States Cancer Biologics Market Size 2014-2019 (Million US$)
Table United States Key Players Cancer Biologics Revenue (2018-2019) (Million US$)
Table United States Key Players Cancer Biologics Market Share (2018-2019)
Table United States Cancer Biologics Market Size by Type (2014-2019) (Million US$)
Table United States Cancer Biologics Market Share by Type (2014-2019)
Table United States Cancer Biologics Market Size by Application (2014-2019) (Million US$)
Table United States Cancer Biologics Market Share by Application (2014-2019)
Figure Europe Cancer Biologics Market Size 2014-2019 (Million US$)
Table Europe Key Players Cancer Biologics Revenue (2018-2019) (Million US$)
Table Europe Key Players Cancer Biologics Market Share (2018-2019)
Table Europe Cancer Biologics Market Size by Type (2014-2019) (Million US$)
Table Europe Cancer Biologics Market Share by Type (2014-2019)
Table Europe Cancer Biologics Market Size by Application (2014-2019) (Million US$)
Table Europe Cancer Biologics Market Share by Application (2014-2019)
Figure China Cancer Biologics Market Size 2014-2019 (Million US$)
Table China Key Players Cancer Biologics Revenue (2018-2019) (Million US$)
Table China Key Players Cancer Biologics Market Share (2018-2019)
Table China Cancer Biologics Market Size by Type (2014-2019) (Million US$)
Table China Cancer Biologics Market Share by Type (2014-2019)
Table China Cancer Biologics Market Size by Application (2014-2019) (Million US$)
Table China Cancer Biologics Market Share by Application (2014-2019)
Figure Japan Cancer Biologics Market Size 2014-2019 (Million US$)
Table Japan Key Players Cancer Biologics Revenue (2018-2019) (Million US$)
Table Japan Key Players Cancer Biologics Market Share (2018-2019)
Table Japan Cancer Biologics Market Size by Type (2014-2019) (Million US$)
Table Japan Cancer Biologics Market Share by Type (2014-2019)
Table Japan Cancer Biologics Market Size by Application (2014-2019) (Million US$)
Table Japan Cancer Biologics Market Share by Application (2014-2019)
Figure Southeast Asia Cancer Biologics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cancer Biologics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cancer Biologics Market Share (2018-2019)
Table Southeast Asia Cancer Biologics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Cancer Biologics Market Share by Type (2014-2019)
Table Southeast Asia Cancer Biologics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Cancer Biologics Market Share by Application (2014-2019)
Figure India Cancer Biologics Market Size 2014-2019 (Million US$)
Table India Key Players Cancer Biologics Revenue (2018-2019) (Million US$)
Table India Key Players Cancer Biologics Market Share (2018-2019)
Table India Cancer Biologics Market Size by Type (2014-2019) (Million US$)
Table India Cancer Biologics Market Share by Type (2014-2019)
Table India Cancer Biologics Market Size by Application (2014-2019) (Million US$)
Table India Cancer Biologics Market Share by Application (2014-2019)
Figure Central & South America Cancer Biologics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cancer Biologics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cancer Biologics Market Share (2018-2019)
Table Central & South America Cancer Biologics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Cancer Biologics Market Share by Type (2014-2019)
Table Central & South America Cancer Biologics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Cancer Biologics Market Share by Application (2014-2019)
Table Roche Company Details
Table Roche Revenue in Cancer Biologics Business (2014-2019) (Million US$)
Figure Roche Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Roche Recent Development
Table Novartis Company Details
Table Novartis Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Novartis Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Eli Lilly Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Sanofi Recent Development
Table Celgene Company Details
Table Celgene Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Celgene Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Pfizer Recent Development
Table Bayer Company Details
Table Bayer Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Bayer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Merck Company Details
Table Merck Revenue in Cancer Biologics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Cancer Biologics Business (2014-2019)
Table Merck Recent Development
Table Amgen Company Details
Table Global Cancer Biologics Market Size by Regions (Million US$) 2019-2025
Figure Global Cancer Biologics Market Size Share by Regions (2019-2025)
Figure Global Cancer Biologics Market Size Share by Regions in 2025
Figure United States Cancer Biologics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cancer Biologics Market Size Forecast (2019-2025)(Million USD)
Figure China Cancer Biologics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cancer Biologics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cancer Biologics Market Size Forecast (2019-2025)(Million USD)
Figure India Cancer Biologics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cancer Biologics Market Size Forecast (2019-2025)(Million USD)
Table Global Cancer Biologics Market Size by Product (2019-2025) (Million US$)
Figure Global Cancer Biologics Market Size by Product (2019-2025)
Figure Global Cancer Biologics Market Size by Product in 2025
Table Global Cancer Biologics Market Size by Application (2019-2025) (Million US$)
Figure Global Cancer Biologics Market Size by Application (2019-2025)
Figure Global Cancer Biologics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"